Generics 36

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Nimodipine manufacturers

36 products found

Filters

36 products found

nimodipine

Capsules 30mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #16206
This company specializes in a wide range of generic medications, offering both prescription (RX) and over-the-counter (OTC) drugs. Their product portfolio spans various therapeutic areas including antiviral, antibiotic, cough medicine, vitamin supplements, sedatives, antiarrhythmic, and migraine medication. They also produce products for involuntary movement reduction, muscle spasms, sleep aids, pain relief, and allergy treatment. The company manufactures its products in a variety of dosage forms, such as capsules, tablets, suspensions, and oral solutions. Key certifications include GMP compliance, ensuring adherence to high quality and manufacturing standards. While specific product patents aren't mentioned, the focus on generic medications suggests they may leverage existing patents or utilize alternative pathways for product development. Their target markets appear to be widespread, with a potential presence in regions like the EU and North America based on the inclusion of popular brand name equivalents in their product descriptions.

Manufacturer usually replies in 53 days

nimodipine

Tablets 30 mg

Dossier type
ACTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18530
This pharmaceutical company specializes in a diverse range of products including prescription medications, over-the-counter drugs, medical devices, and supplements. They hold WHO-GMP certifications since 1965 and an ISO 9001:2015 certification, demonstrating their commitment to quality. Their expertise spans various therapy areas such as oncology/hormone therapies, cardiovascular health, and gastrointestinal conditions. They offer a wide range of dosage forms including capsules, tablets, syrups, and rectal suspensions. This company has a global presence, with products distributed across over 2000 countries. They are known for their contract manufacturing capabilities and new drug development expertise, holding over 300 ACTD dossiers.

Manufacturer usually replies in 5 days

nimodipine

Solution for infusion 10 mg/50 ml - 50 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
ID
Manufacturer #20982
This pharmaceutical company, based in Southeast Asia, has been operating for several decades. They are dedicated to providing quality prescription and over-the-counter medications, emphasizing research and development for continual innovation. They possess a global marketing network, distributing products worldwide, particularly in key regions like Southeast Asia, North America, and Europe. Their key therapeutic areas include cardiology, oncology, and infectious diseases, with a focus on solid dosage forms. The company holds several product patents and adheres to rigorous manufacturing standards, with facilities meeting EU and US GMP requirements.

Want to see all 36 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Nimodipine is a medication used to prevent migraines and treat ischemic stroke, and subarachnoid hemorrhage. Manufacturers of nimodipine produce it both as a standalone medication, in combination with citicoline. Nimodipine suppliers market it in the form of oral capsules, oral solutions, and intravenous liquids. The developer and earliest manufacturer of nimodipine is Bayer, who first introduced it into the pharmaceutical market in 1985 under the trade name Nimotop. Currently, the drug is approved in over 60 countries. Other major suppliers of nimodipine globally include Sun Pharmaceuticals, Heritage Pharmaceuticals, Bionpharma, Arbor, Thepharmanetwork, and Sofgen. Nimodipine suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified nimodipine manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail price per 100 (30mg) capsules of trade name nimodipine is approximately 130,00 EUR, whereas the equivalent amount of generic nimodipine tablets costs around 50,00 EUR to 60,00 EUR. A single vial of trade name 10mg/50ml nimodipine injectable solution costs around 20,00 EUR.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible